Pregnant women needed: study seeks safer HIV prevention dosing
NCT ID NCT06435026
First seen Feb 17, 2026 · Last updated May 20, 2026 · Updated 12 times
Summary
This study looked at how to best give daily HIV prevention pills (PrEP) to pregnant women in Sub-Saharan Africa. Researchers tested different doses of the medication in 54 pregnant volunteers to find the dose that works best and is safest for both mother and baby. The goal is to prevent HIV infection during pregnancy without causing harm.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bwaila District Hospital
Lilongwe, Malawi
-
Seke North CRS
Harare, Zimbabwe
Conditions
Explore the condition pages connected to this study.